KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Boston Scientific (BSX) Other Non Operating Income (2016 - 2025)

Boston Scientific (BSX) has disclosed Other Non Operating Income for 17 consecutive years, with -$384.0 million as the latest value for Q4 2025.

  • Quarterly Other Non Operating Income fell 326.67% to -$384.0 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$319.0 million through Dec 2025, up 0.93% year-over-year, with the annual reading at -$228.0 million for FY2025, 28.97% up from the prior year.
  • Other Non Operating Income hit -$384.0 million in Q4 2025 for Boston Scientific, down from -$23.0 million in the prior quarter.
  • In the past five years, Other Non Operating Income ranged from a high of $181.0 million in Q3 2021 to a low of -$384.0 million in Q4 2025.
  • Historically, Other Non Operating Income has averaged -$27.8 million across 5 years, with a median of -$24.5 million in 2021.
  • Biggest five-year swings in Other Non Operating Income: crashed 500.0% in 2024 and later skyrocketed 222.0% in 2025.
  • Year by year, Other Non Operating Income stood at $26.0 million in 2021, then soared by 123.08% to $58.0 million in 2022, then tumbled by 125.86% to -$15.0 million in 2023, then plummeted by 500.0% to -$90.0 million in 2024, then tumbled by 326.67% to -$384.0 million in 2025.
  • Business Quant data shows Other Non Operating Income for BSX at -$384.0 million in Q4 2025, -$23.0 million in Q3 2025, and $122.0 million in Q2 2025.